152 related articles for article (PubMed ID: 25086620)
1. Stable overexpression of DNA fragmentation factor in T-47D cells: sensitization of breast cancer cells to apoptosis in response to acetazolamide and sulfabenzamide.
Bagheri F; Safarian S; Eslaminejad MB; Sheibani N
Mol Biol Rep; 2014 Nov; 41(11):7387-94. PubMed ID: 25086620
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of breast cancer cells to doxorubicin via stable cell line generation and overexpression of DFF40.
Bagheri F; Safarian S; Eslaminejad MB; Sheibani N
Biochem Cell Biol; 2015 Dec; 93(6):604-10. PubMed ID: 26529233
[TBL] [Abstract][Full Text] [Related]
3. Acetazolamide triggers death inducing autophagy in T-47D breast cancer cells.
Mohammadpour R; Safarian S; Ejeian F; Sheikholya-Lavasani Z; Abdolmohammadi MH; Sheinabi N
Cell Biol Int; 2014 Feb; 38(2):228-38. PubMed ID: 24155029
[TBL] [Abstract][Full Text] [Related]
4. Survivin Promoter-Driven DFF40 Gene Expression Sensitizes Melanoma Cancer Cells to Chemotherapy.
Minaiyan G; Shafiee F; Akbari V
Int J Toxicol; 2021; 40(4):380-387. PubMed ID: 33960240
[TBL] [Abstract][Full Text] [Related]
5. DNA fragmentation factor 40 expression in T cells confers sensibility to tributyltin-induced apoptosis.
Kulbay M; Johnson B; Bernier J
Toxicology; 2019 Oct; 426():152255. PubMed ID: 31401084
[TBL] [Abstract][Full Text] [Related]
6. Modulation of DNA fragmentation factor 40 nuclease activity by poly(ADP-ribose) polymerase-1.
West JD; Ji C; Marnett LJ
J Biol Chem; 2005 Apr; 280(15):15141-7. PubMed ID: 15703174
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic DNA degradation into oligonucleosomal fragments, but not apoptotic nuclear morphology, relies on a cytosolic pool of DFF40/CAD endonuclease.
Iglesias-Guimarais V; Gil-Guiñon E; Gabernet G; García-Belinchón M; Sánchez-Osuna M; Casanelles E; Comella JX; Yuste VJ
J Biol Chem; 2012 Mar; 287(10):7766-79. PubMed ID: 22253444
[TBL] [Abstract][Full Text] [Related]
8. DFF40 deficiency in cancerous T cells is implicated in chemotherapy drug sensitivity and resistance through the regulation of the apoptotic pathway.
Kulbay M; Johnson B; Fiola S; Diaz RJ; Bernier J
Biochem Pharmacol; 2021 Dec; 194():114801. PubMed ID: 34678222
[TBL] [Abstract][Full Text] [Related]
9. Design and characterization of a recombinant immunotoxin for targeted therapy of breast cancer cells: In vitro and in silico analyses.
Barazesh M; Mohammadi S; Jalili S; Kavousipour S; Faraji SN; Mokarram P; Pirhadi S
Life Sci; 2021 Jan; 265():118866. PubMed ID: 33301810
[TBL] [Abstract][Full Text] [Related]
10. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.
Banas T; Pitynski K; Okon K; Winiarska A
BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556
[TBL] [Abstract][Full Text] [Related]
11. siRNA-mediated knock-down of DFF45 amplifies doxorubicin therapeutic effects in breast cancer cells.
Bagheri F; Safarian S; Eslaminejad MB; Sheibani N
Cell Oncol (Dordr); 2013 Dec; 36(6):515-26. PubMed ID: 24277473
[TBL] [Abstract][Full Text] [Related]
12. DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells.
Amrollahi-Nia R; Akbari V; Shafiee F
Biotechnol Lett; 2021 Oct; 43(10):1967-1976. PubMed ID: 34482510
[TBL] [Abstract][Full Text] [Related]
13. An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.
Sánchez-Osuna M; Martínez-Escardó L; Granados-Colomina C; Martínez-Soler F; Pascual-Guiral S; Iglesias-Guimarais V; Velasco R; Plans G; Vidal N; Tortosa A; Barcia C; Bruna J; Yuste VJ
Neuro Oncol; 2016 Jul; 18(7):950-61. PubMed ID: 26755073
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF-DFF40: a novel humanized immunotoxin induces apoptosis in acute myeloid leukemia cells.
Mathew M; Zaineb KC; Verma RS
Apoptosis; 2013 Jul; 18(7):882-95. PubMed ID: 23529188
[TBL] [Abstract][Full Text] [Related]
15. Histone H1 subtype preferences of DFF40 and possible nuclear localization of DFF40/45 in normal and trichostatin A-treated NB4 leukemic cells.
Ninios YP; Sekeri-Pataryas KE; Sourlingas TG
Apoptosis; 2010 Feb; 15(2):128-38. PubMed ID: 19882353
[TBL] [Abstract][Full Text] [Related]
16. Caspase-activated DNase is necessary and sufficient for oligonucleosomal DNA breakdown, but not for chromatin disassembly during caspase-dependent apoptosis of LN-18 glioblastoma cells.
Sánchez-Osuna M; Garcia-Belinchón M; Iglesias-Guimarais V; Gil-Guiñón E; Casanelles E; Yuste VJ
J Biol Chem; 2014 Jul; 289(27):18752-69. PubMed ID: 24838313
[TBL] [Abstract][Full Text] [Related]
17. T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma.
Luciano F; Ricci JE; Herrant M; Bertolotto C; Mari B; Cousin JL; Auberger P
Leukemia; 2002 Apr; 16(4):700-7. PubMed ID: 11960352
[TBL] [Abstract][Full Text] [Related]
18. Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
Gu J; Dong RP; Zhang C; McLaughlin DF; Wu MX; Schlossman SF
J Biol Chem; 1999 Jul; 274(30):20759-62. PubMed ID: 10409614
[TBL] [Abstract][Full Text] [Related]
19. The role of the DFF40/CAD endonuclease in genomic stability.
Kulbay M; Bernier-Parker N; Bernier J
Apoptosis; 2021 Feb; 26(1-2):9-23. PubMed ID: 33387146
[TBL] [Abstract][Full Text] [Related]
20. Regional and temporal alterations in DNA fragmentation factor (DFF)-like proteins following experimental brain trauma in the rat.
Zhang C; Raghupathi R; Saatman KE; LaPlaca MC; McIntosh TK
J Neurochem; 1999 Oct; 73(4):1650-9. PubMed ID: 10501212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
